ROYAL BANK OF CANADA - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 63 filers reported holding SATSUMA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$0
-100.0%
93
-94.8%
0.00%
Q2 2021$13,000
+85.7%
1,774
+43.5%
0.00%
Q1 2021$7,000
+40.0%
1,236
+25.2%
0.00%
Q4 2020$5,000987
+8125.0%
0.00%
Q2 2020$0
-100.0%
12
-96.3%
0.00%
Q1 2020$6,0000.0%321
+6.6%
0.00%
Q4 2019$6,0003010.00%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
CAXTON CORP 870,820$13,071,00014.74%
RA Capital Management 4,681,858$70,275,0004.19%
Cormorant Asset Management, LP 858,382$12,884,0000.78%
Monashee Investment Management LLC 62,500$938,0000.43%
TPG Group Holdings (SBS) Advisors, Inc. 3,771,878$56,616,0000.42%
DC Investments Management, LLC 35,502$533,0000.31%
Eventide Asset Management 425,000$6,379,0000.21%
ADAGE CAPITAL PARTNERS GP, L.L.C. 610,000$9,156,0000.02%
Weiss Asset Management LP 14,150$212,0000.02%
Zimmer Partners, LP 100,000$1,501,0000.02%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders